Ads
related to: treatment for systemic lupus erythematosusContact our dedicated support team for help e-prescribing. Complete the patient start form to begin.
- Official HCP Resources
Download professional resources
for you and your practice.
- Safety & Efficacy Data
View safety and efficacy profile
assessed in clinical trials.
- Important Safety Info
Visit Official HCP Website
for full product information.
- Dosing & Administration
See recommendations for dosing
and administration instructions.
- Official HCP Resources
Search results
Results from the WOW.Com Content Network
The NHS says lupus, or systemic lupus erythematosus, is a long-term condition that subverts the immune system, causing the body’s natural defence measures to turn on healthy organs. There is ...
Lupus, formally called systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. [1] Symptoms vary among people and may be mild to severe. [ 1 ]
Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. [1] Symptoms of these diseases can affect many different body systems, including joints , skin , kidneys , blood cells , heart , and lungs .
In systemic lupus erythematosus patients, BAFF is overexpressed, which may cause autoimmune B cell proliferation and survival. Belimumab binds to BAFF and prevents it from binding to B cells. Without BAFF, B cells commit suicide and no longer contribute to the autoimmune damage of systemic lupus erythematosus. [medical citation needed]
Cutaneous lupus mostly affects the skin, while systemic lupus erythematosus (SLE) can affect multiple aspects of your body. ... Certain lupus treatments, which may have hair loss as a side effect ...
Anifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus. [5] [7] It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β. [medical citation needed]
Telitacicept (trade name Tai'ai) is a pharmaceutical drug used for the treatment of systemic lupus erythematosus (SLE). [1] It is being developed by Yantai Rongchang Pharmaceuticals and RemeGen for various autoimmune diseases. [2] In 2021, telitacicept was approved in China for the treatment of patients with active SLE. [3]
Cutaneous vasculitis is the most common type of vasulitis amongst those with systemic lupus erythematosus. [7] The clinical presentation is variable and can include superficial ulcerations, splinter hemorrhages, panniculitis, macules, erythema with necrosis or erythematous plaques, cutaneous infarction, livedo reticularis, bullous lesions of the extremities or urticaria lesions, papulonodular ...
Ads
related to: treatment for systemic lupus erythematosus